TY - JOUR
T1 - Remote ischemic conditioning provides humoural cross-species cardioprotection through glycine receptor activation
AU - Alburquerque-Béjar, Juan José
AU - Barba, Ignasi
AU - Valls-Lacalle, Laura
AU - Ruiz-Meana, Marisol
AU - Pecoraro, Michela
AU - Rodriguez-Sinovas, Antonio
AU - Garcia-Dorado, David
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Aims Remote ischaemic conditioning (RIC) releases a humoural factor able to exert cross-species cardioprotection when plasma dialysate is applied to isolated hearts. However, the exact chemical nature of this factor is currently unknown. Methods and results RIC (4 - 5min femoral occlusion/5min reperfusion) was applied to 10 male pigs, and blood was taken before and after the manoeuvre. Discriminant analysis of 1H-NMR spectra (n = 10-12) obtained from plasma dialysates (12-14 kDa cut-off) allowed to demonstrate a different metabolic profile between control and postRIC samples, with lactate (2.671 ± 0.294 vs. 3.666 ± 0.291 lmol/mL, P = 0.020), succinate (0.062 ± 0.005 vs. 0.082 ± 0.008 lmol/mL, P = 0.035) and glycine (0.055 ± 0.009 vs. 0.471 ± 0.151 lmol/mL, P = 0.015) being the main responsible for such differences. Plasma dialysates were then given to isolated mice hearts submitted to global ischaemia (35 min) and reperfusion (60 min), for 30 min before ischaemia or during the first 15 min of reflow. Infarct size was significantly reduced when postRIC dialysate was applied before ischaemia as compared with hearts pretreated with control dialysate (44.81 ± 3.22 vs. 55.55 ± 2.53%, P = 0.012, n = 12). Blockade of glycine receptors with strychnine 10 lM inhibited the protective effect caused by pretreatment with postRIC dialysate (52.76 ± 6.94 vs. 51.92 ± 5.78%, P-NS, n = 5), whereas pretreatment with glycine 3 mmol/L, but not succinate 100 lmol/L, mimicked RIC protection (41.90 ± 4.50% in glycine-treated vs. 61.51 ± 5.16 and 64.73 ± 4.47% in succinate-treated and control hearts, respectively, P < 0.05, n = 4-7). Conclusions RIC releases glycine and exerts cross-species cardioprotection against infarction through glycine receptor activation.
AB - Aims Remote ischaemic conditioning (RIC) releases a humoural factor able to exert cross-species cardioprotection when plasma dialysate is applied to isolated hearts. However, the exact chemical nature of this factor is currently unknown. Methods and results RIC (4 - 5min femoral occlusion/5min reperfusion) was applied to 10 male pigs, and blood was taken before and after the manoeuvre. Discriminant analysis of 1H-NMR spectra (n = 10-12) obtained from plasma dialysates (12-14 kDa cut-off) allowed to demonstrate a different metabolic profile between control and postRIC samples, with lactate (2.671 ± 0.294 vs. 3.666 ± 0.291 lmol/mL, P = 0.020), succinate (0.062 ± 0.005 vs. 0.082 ± 0.008 lmol/mL, P = 0.035) and glycine (0.055 ± 0.009 vs. 0.471 ± 0.151 lmol/mL, P = 0.015) being the main responsible for such differences. Plasma dialysates were then given to isolated mice hearts submitted to global ischaemia (35 min) and reperfusion (60 min), for 30 min before ischaemia or during the first 15 min of reflow. Infarct size was significantly reduced when postRIC dialysate was applied before ischaemia as compared with hearts pretreated with control dialysate (44.81 ± 3.22 vs. 55.55 ± 2.53%, P = 0.012, n = 12). Blockade of glycine receptors with strychnine 10 lM inhibited the protective effect caused by pretreatment with postRIC dialysate (52.76 ± 6.94 vs. 51.92 ± 5.78%, P-NS, n = 5), whereas pretreatment with glycine 3 mmol/L, but not succinate 100 lmol/L, mimicked RIC protection (41.90 ± 4.50% in glycine-treated vs. 61.51 ± 5.16 and 64.73 ± 4.47% in succinate-treated and control hearts, respectively, P < 0.05, n = 4-7). Conclusions RIC releases glycine and exerts cross-species cardioprotection against infarction through glycine receptor activation.
KW - Glycine
KW - Infarction
KW - Nuclear magnetic resonance
KW - Remote ischaemic conditioning
U2 - 10.1093/cvr/cvw242
DO - 10.1093/cvr/cvw242
M3 - Article
SN - 0008-6363
VL - 113
SP - 52
EP - 60
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 1
ER -